About
Wonderlab Bio develops HLA-matched allogeneic induced pluripotent stem cell (iPSC) therapies and research tools, enabling off-the-shelf cell therapies without immune rejection and supporting AI drug discovery and regenerative medicine.
Explore Wonderlab Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.